• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于药房的成本分组模型:针对荷兰的情况验证和调整慢性病药物分类。

The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.

作者信息

Lamers Leida M, van Vliet René C J A

机构信息

Department of Health Policy and Management, Erasmus MC (University Medical Center Rotterdam), P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.

出版信息

Health Policy. 2004 Apr;68(1):113-21. doi: 10.1016/j.healthpol.2003.09.001.

DOI:10.1016/j.healthpol.2003.09.001
PMID:15033558
Abstract

In 2002, the Dutch government implemented a Pharmacy-based Cost Group (PCG) model in the social health insurance sector. This model uses specific types of medication prescribed to individuals in a base year as markers for chronic conditions, which are then employed to adjust capitation payments to their sickness fund in the subsequent year. In this study, a classification of prescribed medication is derived for 22 chronic conditions, based on an assessment of the relation between prescribed medication and diagnoses indicated by physicians on their prescriptions. Of the 22 chronic conditions in this classification, 13 were included in the PCG model that is currently used in the Netherlands.

摘要

2002年,荷兰政府在社会医疗保险部门实施了基于药房的成本分组(PCG)模式。该模式将基准年中开给个人的特定类型药物用作慢性病的标志物,然后用于调整次年向其疾病基金支付的人头费。在本研究中,基于对所开药物与医生处方上所示诊断之间关系的评估,得出了22种慢性病的处方药物分类。在该分类中的22种慢性病中,有13种被纳入荷兰目前使用的PCG模式。

相似文献

1
The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.基于药房的成本分组模型:针对荷兰的情况验证和调整慢性病药物分类。
Health Policy. 2004 Apr;68(1):113-21. doi: 10.1016/j.healthpol.2003.09.001.
2
Health-based risk adjustment Improving the pharmacy-based cost group model to reduce gaming possibilities.
Eur J Health Econ. 2003;4(2):107-14. doi: 10.1007/s10198-002-0159-9.
3
Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information.基于诊断成本组模型的风险调整后按人头付费:一项基于健康调查信息的实证评估
Health Serv Res. 1999 Feb;33(6):1727-44.
4
Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs.药房成本分组:一种基于处方药使用情况的人头费支付风险调整器。
Med Care. 1999 Aug;37(8):824-30. doi: 10.1097/00005650-199908000-00012.
5
Data confirm importance of health status adjustment.
Capitation Rates Data. 2000 Jun;5(6):64-5.
6
Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management.临床风险组(CRGs):一种基于风险调整的按人头付费和医疗保健管理的分类系统。
Med Care. 2004 Jan;42(1):81-90. doi: 10.1097/01.mlr.0000102367.93252.70.
7
Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.门诊处方药费用分担计划实施后药物使用情况的变化——来自台湾老年人的证据
Health Policy. 2004 Jun;68(3):277-87. doi: 10.1016/j.healthpol.2003.12.013.
8
Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions.运用慢性病药物分类解释基层医疗保健药房支出。
Health Policy. 2011 Nov;103(1):9-15. doi: 10.1016/j.healthpol.2011.08.014. Epub 2011 Sep 28.
9
The effect of a closed formulary on prescription drug use and costs.封闭式药品目录对处方药使用及费用的影响。
Inquiry. 1999;36(4):481-91.
10
Measuring population health risks using inpatient diagnoses and outpatient pharmacy data.利用住院诊断和门诊药房数据测量人群健康风险。
Health Serv Res. 2001 Dec;36(6 Pt 2):180-93.

引用本文的文献

1
Lifetime Healthcare and Long-Term Care Costs of Heart Failure: Estimates Using Administrative Data from Hospitalized Patients in the Netherlands.心力衰竭的终身医疗保健和长期护理成本:使用荷兰住院患者行政数据的估计
Pharmacoeconomics. 2025 Aug 18. doi: 10.1007/s40273-025-01533-9.
2
Effects of specialised physiotherapy on mortality in Parkinson's disease: a prospective observational study.专业物理治疗对帕金森病死亡率的影响:一项前瞻性观察研究。
NPJ Parkinsons Dis. 2025 Jul 15;11(1):214. doi: 10.1038/s41531-025-01069-x.
3
Validation of Medication Proxies for the Identification of Hospitalizations for Major Adverse Cerebro-Cardiovascular Events.
用于识别重大不良心脑血管事件住院情况的药物替代指标的验证
Clin Epidemiol. 2025 Mar 28;17:327-336. doi: 10.2147/CLEP.S508754. eCollection 2025.
4
A decision rule algorithm for the detection of patients with hypertension using claims data.一种利用理赔数据检测高血压患者的决策规则算法。
J Diabetes Metab Disord. 2024 Dec 20;24(1):21. doi: 10.1007/s40200-024-01519-y. eCollection 2025 Jun.
5
Risk Adjustment in Health Insurance Markets: Do Not Overlook the "Real" Healthy.健康保险市场中的风险调整:勿忽视“真正”的健康人群。
Med Care. 2024 Nov 1;62(11):767-772. doi: 10.1097/MLR.0000000000001955. Epub 2023 Dec 4.
6
Ambient temperature and kidney function in primary care patients.环境温度与基层医疗患者的肾功能。
J Nephrol. 2024 Jan;37(1):95-105. doi: 10.1007/s40620-023-01715-8. Epub 2023 Aug 23.
7
Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018.瑞士乌里州首个有组织的筛查项目实施后结直肠癌(CRC)检测率的变化:来自2010年至2018年保险理赔数据分析的证据
Prev Med Rep. 2022 Jun 10;28:101851. doi: 10.1016/j.pmedr.2022.101851. eCollection 2022 Aug.
8
Exploring Patient Multimorbidity and Complexity Using Health Insurance Claims Data: A Cluster Analysis Approach.利用医疗保险理赔数据探索患者的多种疾病及复杂性:一种聚类分析方法。
JMIR Med Inform. 2022 Apr 4;10(4):e34274. doi: 10.2196/34274.
9
Continuity of care and multimorbidity in the 50+ Swiss population: An analysis of claims data.瑞士50岁以上人群的连续性医疗与多重疾病:索赔数据分析
SSM Popul Health. 2022 Mar 9;17:101063. doi: 10.1016/j.ssmph.2022.101063. eCollection 2022 Mar.
10
Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls.与匹配的对照组相比,慢性肾脏病患者在接受和未接受肾脏替代治疗时的多重用药情况及药物使用情况。
Clin Kidney J. 2021 Jul 6;14(12):2497-2523. doi: 10.1093/ckj/sfab120. eCollection 2021 Dec.